G. Charles Robb

2016

In 2016, G. Charles Robb earned a total compensation of $897.7K as Chief Financial Officer and Secretary at Corcept Therapeutics, a 15% increase compared to previous year.

Compensation breakdown

Bonus$146,000
Option Awards$377,015
Salary$374,685
Total$897,700

Robb received $377K in option awards, accounting for 42% of the total pay in 2016.

Robb also received $146K in bonus and $374.7K in salary.

Rankings

In 2016, G. Charles Robb's compensation ranked 8,753rd out of 14,075 executives tracked by ExecPay. In other words, Robb earned more than 37.8% of executives.

ClassificationRankingPercentile
All
8,753
out of 14,075
38th
Division
Manufacturing
3,380
out of 5,489
38th
Major group
Chemicals And Allied Products
1,149
out of 1,895
39th
Industry group
Drugs
902
out of 1,538
41st
Industry
Pharmaceutical Preparations
719
out of 1,176
39th
Source: SEC filing on April 21, 2017.

Robb's colleagues

We found two more compensation records of executives who worked with G. Charles Robb at Corcept Therapeutics in 2016.

2016

Joseph Belanoff

Corcept Therapeutics

Chief Executive Officer

2016

Robert Fishman

Corcept Therapeutics

Chief Medical Officer

News

You may also like